These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31391529)

  • 21. Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations.
    Mandarano AH; Maya J; Giloteaux L; Peterson DL; Maynard M; Gottschalk CG; Hanson MR
    J Clin Invest; 2020 Mar; 130(3):1491-1505. PubMed ID: 31830003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripheral endothelial dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome.
    Scherbakov N; Szklarski M; Hartwig J; Sotzny F; Lorenz S; Meyer A; Grabowski P; Doehner W; Scheibenbogen C
    ESC Heart Fail; 2020 Jun; 7(3):1064-1071. PubMed ID: 32154656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered endothelial dysfunction-related miRs in plasma from ME/CFS patients.
    Blauensteiner J; Bertinat R; León LE; Riederer M; Sepúlveda N; Westermeier F
    Sci Rep; 2021 May; 11(1):10604. PubMed ID: 34011981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The expression signature of very long non-coding RNA in myalgic encephalomyelitis/chronic fatigue syndrome.
    Yang CA; Bauer S; Ho YC; Sotzny F; Chang JG; Scheibenbogen C
    J Transl Med; 2018 Aug; 16(1):231. PubMed ID: 30119681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing diagnostic value of microRNAs from peripheral blood mononuclear cells and extracellular vesicles in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Almenar-Pérez E; Sarría L; Nathanson L; Oltra E
    Sci Rep; 2020 Feb; 10(1):2064. PubMed ID: 32034172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD24 Expression and B Cell Maturation Shows a Novel Link With Energy Metabolism: Potential Implications for Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Mensah FFK; Armstrong CW; Reddy V; Bansal AS; Berkovitz S; Leandro MJ; Cambridge G
    Front Immunol; 2018; 9():2421. PubMed ID: 30405620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating levels of GDF15 in patients with myalgic encephalomyelitis/chronic fatigue syndrome.
    Melvin A; Lacerda E; Dockrell HM; O'Rahilly S; Nacul L
    J Transl Med; 2019 Dec; 17(1):409. PubMed ID: 31801546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Isolated Complex V Inefficiency and Dysregulated Mitochondrial Function in Immortalized Lymphocytes from ME/CFS Patients.
    Missailidis D; Annesley SJ; Allan CY; Sanislav O; Lidbury BA; Lewis DP; Fisher PR
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32041178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNAs hsa-miR-99b, hsa-miR-330, hsa-miR-126 and hsa-miR-30c: Potential Diagnostic Biomarkers in Natural Killer (NK) Cells of Patients with Chronic Fatigue Syndrome (CFS)/ Myalgic Encephalomyelitis (ME).
    Petty RD; McCarthy NE; Le Dieu R; Kerr JR
    PLoS One; 2016; 11(3):e0150904. PubMed ID: 26967895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Long-Term Cryopreservation on Blood Immune Cell Markers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Implications for Biomarker Discovery.
    Gómez-Mora E; Carrillo J; Urrea V; Rigau J; Alegre J; Cabrera C; Oltra E; Castro-Marrero J; Blanco J
    Front Immunol; 2020; 11():582330. PubMed ID: 33329554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Could mitochondrial dysfunction be a differentiating marker between chronic fatigue syndrome and fibromyalgia?
    Castro-Marrero J; Cordero MD; Sáez-Francas N; Jimenez-Gutierrez C; Aguilar-Montilla FJ; Aliste L; Alegre-Martin J
    Antioxid Redox Signal; 2013 Nov; 19(15):1855-60. PubMed ID: 23600892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Problems in defining post-exertional malaise.
    Jason LA; Evans M; So S; Scott J; Brown A
    J Prev Interv Community; 2015; 43(1):20-31. PubMed ID: 25584525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychometric properties of the PROMIS
    Yang M; Keller S; Lin JS
    Qual Life Res; 2019 Dec; 28(12):3375-3384. PubMed ID: 31506915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of T and NK Cell Phenotype With the Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    Rivas JL; Palencia T; Fernández G; García M
    Front Immunol; 2018; 9():1028. PubMed ID: 29867995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in the transcriptome of circulating immune cells of a New Zealand cohort with myalgic encephalomyelitis/chronic fatigue syndrome.
    Sweetman E; Ryan M; Edgar C; MacKay A; Vallings R; Tate W
    Int J Immunopathol Pharmacol; 2019; 33():2058738418820402. PubMed ID: 30791746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Role of Transient Receptor Potential Melastatin 3 Ion Channels in Pathophysiology and Treatment.
    Cabanas H; Muraki K; Eaton-Fitch N; Staines DR; Marshall-Gradisnik S
    Front Immunol; 2021; 12():687806. PubMed ID: 34326841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-associated DNA methylation patterns.
    Trivedi MS; Oltra E; Sarria L; Rose N; Beljanski V; Fletcher MA; Klimas NG; Nathanson L
    PLoS One; 2018; 13(7):e0201066. PubMed ID: 30036399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic sensitivity of 2-day cardiopulmonary exercise testing in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Nelson MJ; Buckley JD; Thomson RL; Clark D; Kwiatek R; Davison K
    J Transl Med; 2019 Mar; 17(1):80. PubMed ID: 30871578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome.
    Hoel F; Hoel A; Pettersen IK; Rekeland IG; Risa K; Alme K; Sørland K; Fosså A; Lien K; Herder I; Thürmer HL; Gotaas ME; Schäfer C; Berge RK; Sommerfelt K; Marti HP; Dahl O; Mella O; Fluge Ø; Tronstad KJ
    JCI Insight; 2021 Aug; 6(16):. PubMed ID: 34423789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome.
    Landi A; Broadhurst D; Vernon SD; Tyrrell DL; Houghton M
    Cytokine; 2016 Feb; 78():27-36. PubMed ID: 26615570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.